Showing posts with label aspirin. Show all posts
Showing posts with label aspirin. Show all posts

Tuesday, February 27, 2024

Aspirin: Ancient Roots, Modern Science

The evolution of aspirin represents a significant milestone in medical history, showcasing a fascinating fusion of ancient wisdom with modern scientific advancements. Originating from natural salicylates found in plants such as the willow tree, which have been utilized since ancient times for pain relief, aspirin's journey epitomizes the seamless integration of traditional remedies with contemporary innovation.

The narrative of aspirin can be traced back to the ancient Roman era, where salicylates derived from plants like willow were recognized for their pain-relieving properties. As early as 400 B.C., Hippocrates himself endorsed the use of willow leaf tea for alleviating discomfort. However, it wasn't until the 19th century that scientists commenced unraveling the active ingredients responsible for these effects.

A pivotal moment occurred in 1763 when Edward Stone's discovery of willow bark's efficacy against fevers, presented to the Royal Society of London, sparked significant interest. This eventually led to the identification of salicylic acid as the active compound. Nonetheless, its direct application proved problematic due to severe stomach irritation.

Fast forward to 1897, when German chemist Felix Hoffmann, driven by his father's arthritis, successfully synthesized acetylsalicylic acid—the pure form of aspirin. This breakthrough laid the groundwork for Bayer's mass production of aspirin, which swiftly gained acclaim for its effectiveness and relatively minimal side effects compared to previous alternatives.

The medical community's comprehension of aspirin's mechanism of action continued to evolve over time. In 1948, Dr. Lawrence Craven observed a significant correlation between aspirin usage and reduced heart attack risk among his patients, prompting widespread recommendations for daily aspirin intake for cardiovascular health.

However, it wasn't until 1971 that the mechanism behind aspirin's effects was fully elucidated. John Vane's groundbreaking research demonstrated that aspirin inhibits prostaglandin synthesis, thereby alleviating symptoms such as fever, pain, inflammation, and menstrual cramps by modulating the body's immune responses.

The dual identity of aspirin, bridging ancient herbal medicine with modern pharmaceutical science, underscores its enduring significance. Its accessibility, rapid action, specificity, and mild side effects make it a quintessential example of a synthetic drug that revolutionized medicine.

Furthermore, aspirin's journey emphasizes the collaborative efforts of scientists spanning centuries and continents, from Edward Stone's initial discovery to Felix Hoffmann's synthesis and John Vane's mechanistic elucidation. Their collective contributions have not only deepened our understanding of pharmacology but also revolutionized clinical practice, providing relief and protection to millions worldwide.

In essence, aspirin serves as a testament to the convergence of historical knowledge and scientific advancement. From ancient remedies to cutting-edge pharmaceuticals, its story embodies humanity's timeless pursuit of alleviating suffering and enhancing human health.
Aspirin: Ancient Roots, Modern Science

Wednesday, January 10, 2018

Dr. Lawrence Craven and clinical trial of aspirin

The antiplatelet effects of aspirin were first noticed by Dr. Lawrence Craven. He was first to describe the potential of aspirin to prevent heart attacks. Dr. Lawrence Craven, a California general practitioner, in 1948, notices that the 400 men he prescribed aspirin to hadn't suffered any heart attacks.

He published his results in a minor medical journal, the Mississippi Valley Medical Journal in 1953.

He also concluded that men suffered more heart attacks than women due to the fact that they were less likely to engage in the taking of medication. He regularly recommends to all patients and colleagues that "an aspirin a day" could dramatically reduce the risk of heart attack.

Dr. Lawrence was born in Iowa in 1883, and a graduate with a MD from the University of Minnesota College of Medicine and Surgery right before entering into service in the First World War.
Dr. Lawrence Craven and clinical trial of aspirin

Tuesday, February 28, 2017

Discovery of salicylic acid by Edward Stone

About 3500 years ago Ebers papyrus recommended a decoction of dried leaves of myrtle to cure rheumatic pains.

Hippocrates favored the juices of the popular tree against eye diseases and those of Willow bark in case of pain in childbirth and against fever. The active ingredient of both these remedies is salicylic acid - aspirin’s active ingredient.

One summer day in 1758, an English clergyman named Edward Stone was walking along a brook near Chipping Norton, past some willow trees. For reasons that are not recorded, he put a strip of the bark to his lips and noticed that it tasted bitter.

He knew that the bitter tasting bark of the South American cinchona tree was used as a treatment for malaria, and argued that willow bark might have similar curative properties.

On June 2, 1763, he read a paper to the Royal Society of London entitles “An Account of the Success of the Bark of the Willow the cure of Agues.” By ague, Stone was referring to what now call malaria, but his use of the word cure was optimistic; what his extract of willow bark actually did was to reduce the feverish symptom of the disease.

He described chewing dried bark from Willow trees: “…Which I have found by experience to be powerful astringent and very efficacious in curing anguish and intermitting disorders.”

The substance was named salicylic acid. But when people suffering from pain took the salicylic acid, it caused severe stomach and mouth irritation. In 1899 German chemist working for Bayer, then a dye company found that acetyl salicylic acid was much convenient to take.
Discovery of salicylic acid by Edward Stone

Tuesday, June 21, 2016

Sir John Robert Vane and aspirin

Aspirin is the most widely used painkiller in the world. It has been used to treat toothaches, headaches, arthritis, and other painful maladies for 100 years. Credit for influencing physicians to prescribe aspirin for heart problems must be given to Sir John Robert Vane (1927-2004).

In 1971, the Journal Nature published three papers of the group of John Vane, the then Professor of Pharmacology at the Royal College of Surgeons of England.

In his pioneering articles, Vane demonstrated for the first time a new mode of action of aspirin that was able to explain its anti-inflammation and antipyretic actions by one single pharmacology mechanisms: inhibition of biosynthesis of prostaglandins, a group of pro-inflammatory pain mediators.

The action prevents blood from clumping together to produce a clot. Thus aspirin is referred to as an anti-platelet agent that is a mild blood thinner.

John Vane’s breakthrough discovery was followed by several other discoveries which also helped to build up the full picture of how aspirin worked.

These findings of John Vane and the discovery of prostacyclin 5 years later were honored by the Nobel Prize for Medicine awarded to him in 1982.
Sir John Robert Vane and aspirin

Tuesday, October 14, 2014

The understanding how aspirin works

Aspirin is the most widely used painkiller in the world. It has been used to treat toothaches, headaches, arthritis and other painful maladies for 100 years.

John Vane is credited for influencing physicians to prescribe aspirin for heart problems. He showed that aspirin blocs the action of special substances in the body called prostaglandins.

On June 23, 1971, the journal Nature published three articles of the group of John Vane at the Royal College of Surgeons of England, which sent shock waves across the world.

These articles demonstrated for the first time a mechanism of action of aspirin that explained the multiple biological activities of the compound by one single pharmacological effect: inhibition of prostaglandin biosynthesis.

Prostaglandins play important regulatory roles in life processes such as digestion, blood circulation and production.

In his pioneering paper, the later Sir John Vane showed by elegant bioassay experiments that aspirin - and salicylate – preventing the synthesis of prostaglandin in cell free systems after tissue injury.

Thus, aspirin is referred to as an antiplatelet agent that is a mild blood thinner.

In the same year an informative paper was published by William L. Smith and William E. M. Lands. Using acetone powder preparations of sheep vesicular glands they demonstrated time-dependent aspirin and indomethacin inhibition, with indomethacin 100 times as effective.
The understanding how aspirin works

Wednesday, October 1, 2014

Felix Hoffmann and aspirin

Felix Hoffmann (1868-1946) was the son of a manufacturer in the town of Ludwigsburg in Swabia Germany. He studied chemistry and pharmacy at the University of Munich, graduating in 1893.

Legend has it that Hoffmann was searching for something to relieve his father's arthritis. His father was using salicylic acid a precursor to aspirin, for his condition in the late 19th century.

Hoffmann prepared a range of compounds by making slight modification to the structure of 2-hydroxybenzoic acid.
Dr. Felix Hoffmann
Hoffmann tried out each of the new preparations on his father the effects. Within a two-week period in August 897 Hoffmann synthesized two drugs: aspirin and heroin.

On October 10, 1897, he prepared aspirin in a purer form using an improved process. Hoffman gave some of his aspirin to his father and it worked well in relieving arthritis pain.

Aspirin reduces pain and fever by reducing the production of prostaglandins, inflammatory compounds released when cells are damaged.

The problem was that aspirin is not very soluble in water. It was first available as a powder in sachets.

Bayer then decided to pellet the powder and aspirin became the first medicine to be sold as tablets.
Felix Hoffmann and aspirin 

Tuesday, September 16, 2014

Discovery of aspirin

Aspirin or acetylsalicylic acid is a derivative of salicylic acid. It is useful in the relief of headache and muscle and joint aches.

The tablet was the precursor of modern mass produced medicines, and has probably cured more minor ills than any other drug.

In 1829, the French pharmacist H. Leroux identified the active element in willow bark to be salicin. In 1853 a chemistry professor at France’s Montpellier University, Karl Friedrich Gerhardt, discovered the molecular structure of salicylic acid.

The use of salicylic acid did not become common until 1853 when Von Gerhardt of Bayer developed aspirin.

In 1897, Felix Hoffmann prepared a more pure of aspirin using an improved method. He had studied Charles Gerhardt’s experiments and ‘rediscovered’ the pain-relieving, fever-lowering and anti-inflammatory acetylsalicylic acid.

In 1899, Hoffmann, a Bayer chemist, used aspirin to treat his father’s rheumatism.

Hoffman’s colleague, Heinrich Dreser, investigated the overall medical effects of the new drug and recognized it to be effective not only as a mild sedative but also as a reducer of fever and inflammations.

In 1899, Hoffman and Dreser coined a new name for that new drug: aspirin – ‘a’ for ‘acetyl’, ‘spir’ for the Spirea plant family and ’in’ to round it off.

In United States Bayer was able to obtain a patent in 1900, giving the company the monopoly on manufacturing the drug aspirin.

The first clinical trial of aspirin in patients occurred from 1948 to 1956 when a general practitioner, Lawrence Craven treated 1500 relatively healthy, overweight, sedentary men between the ages of 40 to 65.

The result reported in the Mississippi Valley Journal is that one aspirin a day was sufficient, because none of Lawrence Craven’s 1500 patients experienced a heart attack over the five-year course of treatment.

In 1971, John R. Vane discovered that aspirin works by blocking cyclooxygenase, thus preventing the synthesis of prostaglandins.
Discovery of aspirin

Saturday, January 20, 2007

The Aspirin

Developed by the Bayer Company, aspirin became the classic ideal of a synthetic drug. It was inexpensive, fast acting, specific and had relatively few serous side effects.

The history of aspirin, dates from early times when salicylates of plant origin were used to deaden pain.

The effects of aspirin-like substances have been known since the ancient Romans recorded the use of the willow bark as a fever fighter.

The leaves and bark of the willow tree contain a substance called salicin, a naturally occurring compound similar to acetylsalicylic acid, the chemical name for aspirin.

Even as far back as 400 B.C. Hippocrates recommended a tea made from yellow leaves.

It wasn't until the 1800's that scientists discovered what was in the willow tree that relieved pain and reduced fever.

On June 2, 1763, Edward Stone, a clergyman read a paper to the Royal Society of London entitles “An Account of the Success of the Bark of the Willow the cure of Agues.” By ague, Stone was referring to what now call malaria, but his use of the word cure was optimistic; what his extract of willow bark actually did was to reduce the feverish symptom of the disease.

The substance was named salicylic acid. But when people suffering from pain took the salicylic acid, it caused sever stomach and mouth irritation.

In 1832, a thirty-seven-year-old French chemist named Charles Gerhardt mixed another chemical with the acid and produced good results, but the procedure was difficult and took a lot of time. Gerhardt decided the new compound wasn't practical, so he set aside.

Sixty-five-years later a German chemist, Felix Hoffmann, was searching for something to relieve his father's arthritis.


He studied Gerhardt's experiments and "rediscovered" acetylsalicylic acid. He first synthesized it in pure form at Bayer in 1897.

Dr. Lawrence Craven, a California general practitioner, in 1948, notices that the 400 men he prescribed aspirin to hadn't suffered any heart attacks.

He regularly recommends to all patients and colleagues that "an aspirin a day" could dramatically reduce the risk of heart attack.

How aspirin worked remained a mystery until 1971 when John Vane at the Institute of Basic Medical Sciences of the University of London and the Royal College of Surgeon of England demonstrated that it blocked prostaglandins synthesis.

He turned again to his bioassay system for the answer and within a few days he had convinced himself and his colleagues that this indeed was the missing mechanism of action.

Aspirin has been shown to prevent bodily synthesis of prostaglandins and this to alleviate the symptomatic portion (fever, pain, inflammation, menstrual cramps) of the body’s immune responses.
The Aspirin

The most popular articles

Selected Articles